Cart
sales@molnova.com
Rovazolac
CAS No. 1454288-88-0
Rovazolac( —— )
Catalog No. M33485 CAS No. 1454288-88-0
Rovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 112 | Get Quote |
|
| 5MG | 170 | Get Quote |
|
| 10MG | 275 | Get Quote |
|
| 25MG | 533 | Get Quote |
|
| 50MG | 821 | Get Quote |
|
| 100MG | 1224 | Get Quote |
|
| 500MG | 2457 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRovazolac
-
NoteResearch use only, not for human use.
-
Brief DescriptionRovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
-
DescriptionRovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLiver X Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1454288-88-0
-
Formula Weight452.45
-
Molecular FormulaC21H19F3N2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 10 mg/mL (22.10 mM; Ultrasonic)
-
SMILESCCOC(=O)Cn1nc(cc1-c1ccc(cc1)-c1cccc(c1)S(C)(=O)=O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
molnova catalog
related products
-
Taurocholic acid
Taurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
-
Methylnissolin-3-O-g...
Methylnissolin-3-O-glucoside has ?anti-inflammatory effectsantioxidant activity.
-
N-Boc-Phe-Leu-Phe-Le...
N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
